HUNTINGTON NATIONAL BANK - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10.0%10.0%0.00%
Q2 2023$10.0%10.0%0.00%
Q1 2023$10.0%10.0%0.00%
Q4 2022$110.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q4 2018$010.0%0.00%
Q3 2018$0
-100.0%
1
-100.0%
0.00%
Q1 2016$11,0000.0%2,5900.0%0.00%
Q1 2015$11,000
+22.2%
2,5900.0%0.00%
Q4 2014$9,000
-96.4%
2,590
-93.5%
0.00%
-100.0%
Q1 2014$252,000
+140.0%
40,000
+100.0%
0.01%
+66.7%
Q3 2013$105,000
-54.1%
20,000
-32.7%
0.00%
-57.1%
Q2 2013$229,000
-6.1%
29,7000.0%0.01%
-12.5%
Q1 2013$244,00029,7000.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 867,700$5,085,0001.68%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,369,066$25,603,0001.03%
Lyons Wealth Management, LLC. 56,775$334,0000.30%
Callan Capital, LLC 66,118$387,0000.10%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 383,050$2,245,0000.06%
FCG ADVISORS, LLC 10,600$62,0000.05%
OppenheimerFunds, Inc. 7,000,000$41,020,0000.04%
NEXT Financial Group, Inc 19,704$86,0000.04%
WELLINGTON MANAGEMENT GROUP LLP 27,893,387$163,455,0000.04%
MURPHY CAPITAL MANAGEMENT INC 45,000$263,0000.04%
View complete list of ARENA PHARMACEUTICALS INC shareholders